BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9398212)

  • 1. Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor.
    Tanner KG
    Biochemistry; 1997 Dec; 36(48):14889-96. PubMed ID: 9398212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of epidermal growth factor receptor by epidermal growth factor.
    Sherrill JM; Kyte J
    Biochemistry; 1996 May; 35(18):5705-18. PubMed ID: 8639530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?
    Groenen LC; Walker F; Burgess AW; Treutlein HR
    Biochemistry; 1997 Apr; 36(13):3826-36. PubMed ID: 9092812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the EGF receptor by insertional mutations in its juxtamembrane regions.
    Sorokin A
    Oncogene; 1995 Oct; 11(8):1531-40. PubMed ID: 7478577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
    Sherrill JM; Kyte J
    Biochemistry; 1999 Mar; 38(10):3106-11. PubMed ID: 10074364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal inactivation of the protein tyrosine kinase of the epidermal growth factor receptor.
    Stein RA; Staros JV
    Biochemistry; 1996 Mar; 35(9):2878-84. PubMed ID: 8608124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
    Ge G; Wu J; Wang Y; Lin Q
    Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction.
    Sherrill JM
    Biochemistry; 1997 Oct; 36(42):12890-6. PubMed ID: 9335547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
    Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
    Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
    Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
    Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications.
    Le PU; Lenferink AE; Pinard M; Baardsnes J; Massie B; O'Connor-McCourt MD
    Protein Expr Purif; 2009 Apr; 64(2):108-17. PubMed ID: 19061959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
    Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
    Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
    van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
    Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficiency of self-phosphorylation for the activation of epidermal growth factor receptor.
    Sherrill JM
    Biochemistry; 1997 May; 36(19):5677-84. PubMed ID: 9153407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
    Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
    Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.
    Neelam B; Richter A; Chamberlin SG; Puddicombe SM; Wood L; Murray MB; Nandagopal K; Niyogi SK; Davies DE
    Biochemistry; 1998 Apr; 37(14):4884-91. PubMed ID: 9538006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.